arsenic trisulfide has been researched along with Malignant Melanoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Ding, W; Kim, S; Liu, J; Ma, Y; Tian, W; Tong, Y; Zhang, L | 1 |
1 other study(ies) available for arsenic trisulfide and Malignant Melanoma
| Article | Year |
|---|---|
Arsenic sulfide as a potential anti‑cancer drug.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenicals; Caspase 3; Caspase 9; Cell Division; Cell Line, Tumor; Cell Proliferation; G2 Phase; Hep G2 Cells; Humans; Hydro-Lyases; Interleukin-2; Male; Melanoma; Mice; Mice, Inbred C57BL; Sulfides; Xenograft Model Antitumor Assays | 2015 |